Corcorran, Maria A. http://orcid.org/0000-0002-4935-5166
Ludwig-Baron, Natasha
Cheng, Debbie M.
Lioznov, Dmitry
Gnatienko, Natalia
Patts, Gregory
So-Armah, Kaku
Blokhina, Elena
Bendiks, Sally
Krupitsky, Evgeny
Samet, Jeffrey H.
Tsui, Judith I.
Funding for this research was provided by:
National Institute of Diabetes and Digestive and Kidney Diseases (5T32DK007742-22)
National Institute on Alcohol Abuse and Alcoholism (U01AA020780, U24AA020779, U24AA020778)
Providence/Boston Center for AIDS Research (P30AI042853)
Article History
Accepted: 26 February 2021
First Online: 17 March 2021
Declarations
:
: Dr. Judith I. Tsui is the site PI for a Patient Centered Outcomes Research Institute (PCORI) funded study, which received donated medications from Gilead. She is also the recipient of a Small Business Innovation Research (SBIR) grant from NIH/NIDA (R44DA044053; PI: Seiguer/Tsui) in partnership with a health technology company, emocha Mobile Health Inc. Dr. Debbie M. Cheng serves on the Data Safety and Monitoring Board for Janssen Research & Development. All other authors, including first author Dr. Maria A. Corcorran, have no conflicts of interest to declare. No pharmaceutical grants were received in the development of this study.
: This study was approved by the Institutional Review Boards of Boston University Medical Campus and First Pavlov State Medical University of St. Petersburg, Russia.
: Informed consent was obtained for all participants prior to enrollment in the St PETER HIV Study. Participants who were unable to provide informed consent were excluded from the study.